Back
ProShares UltraShort Dow30 Vs. Novo Nordisk AS Industry Stock Comparison
Buy
55
DXD
ProShares UltraShort Dow30
Last Price:
$26.79
Seasonality Move:
-3.69%
Sell
26
NVO
Novo Nordisk AS
Last Price:
$87.66
Seasonality Move:
6.4%
Buy
55
ProShares UltraShort Dow30 (DXD)
is a Buy
Is ProShares UltraShort Dow30 a Buy, Sell or Hold?
-
The current ProShares UltraShort Dow30 [DXD] share price is $26.78. The Score for DXD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
DXD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $87.65. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DXD Stock Price Chart
What is ProShares UltraShort Dow30's stock price today?
-
The ProShares UltraShort Dow30 share price today is $26.78The current trend is moderately bullish and DXD is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.65Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.
DXD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.31 | Buy |
Relative Strength Index (14 RSI): | 55.74 | Buy |
Chaikin Money Flow: | -327805 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.78 - 26.84) | Buy |
Bollinger Bands (100): | (25.67 - 29.07) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.01 | Sell |
Relative Strength Index (14 RSI): | 30.1 | Sell |
Chaikin Money Flow: | -992739 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (90.25 - 110.97) | Sell |
Bollinger Bands (100): | (101.58 - 130.52) | Sell |
DXD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.66 | Buy |
20-day SMA: | 26.1 | Buy |
50-day SMA: | 26.19 | Buy |
200-day SMA: | 29.7 | Sell |
8-day EMA: | 26.73 | Buy |
20-day EMA: | 26.35 | Buy |
50-day EMA: | 26.44 | Buy |
200-day EMA: | 29.55 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 87.25 | Buy |
20-day SMA: | 98.78 | Sell |
50-day SMA: | 104.32 | Sell |
200-day SMA: | 124.42 | Sell |
8-day EMA: | 89.14 | Sell |
20-day EMA: | 95.42 | Sell |
50-day EMA: | 103.78 | Sell |
200-day EMA: | 115.72 | Sell |
ProShares UltraShort Dow30 Earnings Growth & DXD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $0.66 per share.
ProShares UltraShort Dow30 Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
18 | 19 | 20 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |